GlassScriptPhysician profile
Brian M Parkes
NPI 1437327376
$93,272.03
in general payments reported to CMS, 2019-2025
7 companies · $9,291 in 2025
The $9,291 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,407 · 2020: $12K · 2021: $27K · 2022: $25K · 2023: $15K · 2024: $59.84 · 2025: $9,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Education: $5,500 · Travel and Lodging: $3,107 · Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,609.04 |
| Education | $5,500.00 |
| Travel and Lodging | $3,107.21 |
| Food and Beverage | $789.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $79,572.85 | 2020-2025 | Miro3d, Miro3d Fibers, Miroderm |
| Intuitive Surgical, INC. | $10,059.68 | 2019-2025 | |
| Miromatrix Medical INC. | $3,438.00 | 2019 | |
| Smith+Nephew, INC. | $114.24 | 2021-2025 | Grafix Pl, Stravix, Oasis |
| Next Science LLC | $34.16 | 2020-2023 | Surgx, Blastx, Xperience |
| Polarityte, INC. | $31.19 | 2019 | |
| Hologic Sales and Service, LLC | $21.91 | 2023 | Biozorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Parkes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.